20/20 Biolabs Stock Price, News & Analysis

AIDX NASDAQ

Company Description

Welcome to the overview page for 20/20 Biolabs (AIDX), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—

0.00%

0.00

Last updated:

-85.79%

Performance 1 year

$39.5M

9.6M

Shares outstanding

Latest News

6 days ago

-28.82%

20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities

AI

SEC Filings

February 25, 2026

[SCHEDULE 13G] Streeterville holds 9.99% of 20/20 Biolabs (AIDX) via warrants and preferred rights

February 24, 2026

[4] Director converts 20/20 Biolabs (AIDX) preferred shares into common stock

February 23, 2026

[4] Director converts AIDX Series A-2 preferred into common on Nasdaq listing

February 23, 2026

[4] Director converts preferred into common at 20/20 Biolabs (AIDX)

February 23, 2026

[4] Director at 20/20 Biolabs (AIDX) converts Series A-2 preferred into common

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of 20/20 Biolabs (AIDX)?

The current stock price of 20/20 Biolabs (AIDX) is $3.39 as of March 2, 2026.

What is the market cap of 20/20 Biolabs (AIDX)?

The market cap of 20/20 Biolabs (AIDX) is approximately 39.5M. Learn more about what market capitalization means .